What is the name of the small cap stocks that Bristol-Myers, Eli Lilly, NVIDIA, and Bill Gates are backing

Small Cap Stocks Backed by Major Players:

1. Bristol-Myers Squibb (BMY): Bristol-Myers Squibb has been involved in collaborations with small-cap biotech companies to expand its drug portfolio. Recently, they forged deals with companies like Halozyme Therapeutics (HALO), which saw a significant increase in its stock price after the partnership was announced.
2. Eli Lilly (LLY): Eli Lilly has been actively involved in the healthcare industry, particularly in weight-loss drugs. They have deals in place with small-cap companies like Altimmune (ALIM), which is developing treatments for metabolic dysfunction-associated steatohepatitis (MASH) and has shown promising results in weight loss.
3. NVIDIA: NVIDIA has invested in several small-cap AI-driven biotech companies, such as Soundhound AI (SOUN), Nano-X Imaging (NNOX), and Recursion Pharmaceuticals (RXRX). These investments have the potential to generate significant returns based on the growth prospects of these companies.
4. Bill Gates: Bill Gates has invested in AI-driven biotech companies through his foundation, the Bill and Melinda Gates Foundation. He has supported companies like BioNTech (BNTX), Vir Biotechnology (VIR), and Immunocore (IMCR), which are at the forefront of developing innovative treatments and technologies in the biotech space.

Conclusion: These major players in the healthcare and technology industries are backing small-cap stocks that have the potential for growth and innovation. Bristol-Myers Squibb, Eli Lilly, NVIDIA, and Bill Gates are leveraging their resources and expertise to support these small companies, which could lead to breakthroughs in disease treatment and technological advancements.